Caricamento...
Metabotropic Glutamate Receptors as Therapeutic Targets for Schizophrenia
Treatment options for schizophrenia that address all symptom categories (positive, negative, and cognitive) are lacking in current therapies for this disorder. Compounds targeting the metabotropic glutamate (mGlu) receptors hold promise as a more comprehensive therapeutic alternative to typical and...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3189289/ https://ncbi.nlm.nih.gov/pubmed/21620876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuropharm.2011.05.005 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|